Lyra Therapeutics, Inc. Common Stock
Symbol: LYRA (NASDAQ)
6.63
▲ (1.59%) 0.104
Company Description:
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.
Key Stats
- Today's Open: $6.3701
- Today's High: $6.853
- Today's Low: $6.535
- Today's Volume: 8.54K
- Yesterday Close: $6.526
- Yesterday High: $6.8099
- Yesterday Low: $6.3601
- Yesterday Volume: 9.05K
- Last Min Volume: 150
- Last Min High: $6.63
- Last Min Low: $6.63
- Last Min VWAP: $6.63
Company Profile
- Name: Lyra Therapeutics, Inc. Common Stock
- Website: https://lyratherapeutics.com
- Listed Date: 2020-05-01
- Location: WATERTOWN, MA
- Market Status: Active
- CIK Number: 0001327273
- SIC Code: 3841
- SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Market Cap: $10.73M
- Round Lot: 100
- Outstanding Shares: 1.64M
- Asset Type: CS
RECENT FILINGS FOR LYRA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-04 | 8-K | View |
| 2025-08-22 | 8-K | View |
| 2025-08-14 | SCHEDULE 13D/A | View |
| 2025-08-12 | 10-Q | View |
| 2025-08-12 | 8-K | View |
| 2025-08-01 | 8-K | View |
| 2025-07-31 | 424B3 | View |
| 2025-07-30 | EFFECT | View |
| 2025-07-28 | CORRESP | View |
| 2025-07-28 | UPLOAD | View |
| 2025-07-22 | S-1 | View |
| 2025-07-14 | 4 | View |
| 2025-07-14 | 4 | View |
| 2025-07-10 | 144 | View |
| 2025-06-27 | 8-K | View |
| 2025-06-27 | 424B5 | View |
| 2025-06-26 | 424B5 | View |
| 2025-06-23 | 8-K | View |
| 2025-06-09 | 8-K | View |
| 2025-06-02 | 8-K | View |
Latest News on LYRA